InvestorsObserver is giving AcelRx Pharmaceuticals Inc (ACRX) an Analyst Rating Rank of 75, meaning ACRX is ranked higher by analysts than 75% of stocks. The average price target for ACRX is $6 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating ACRX a Strong Buy today. Find out what this means to you and get the rest of the rankings on ACRX!